Search results
Is Merck & Co., Inc. (NYSE:MRK) the Best Dow Stock To Buy According to Hedge Funds?
Insider Monkey via Yahoo Finance· 1 day agoWe recently identified the best dow stocks according to hedge funds. Even though Merck & Co., Inc....
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: American Express,...
Zacks via Yahoo Finance· 7 days agoStocks recently featured in the blog include: American Express Co. AXP, Walmart Inc. WMT, Amazon.com...
ASCO24: An early look at cancer drug study results
BioPharma Dive via Yahoo Finance· 3 days agoClinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merus, J&J and Merck & Co...
Why Is Cancer-Focused Merus Stock Trading Over 30% On Friday?
Benzinga via Yahoo Finance· 2 days agoKeytruda (pembrolizumab) is Merck & Co Inc’s (NYSE:MRK) top selling cancer drug. The abstract...
McKesson, Merck back Atropos Health’s $33M round to accelerate drug development with AI
VentureBeat· 3 days agoAtropos Health, a healthcare technology company focused on generating personalized real-world...
Lilly partners with Aktis, deepening radiopharma investment
BioPharma Dive via Yahoo Finance· 5 days agoAnd in 2023, Merck & Co’s venture arm participated in the company’s Series A extension, which raised...
AstraZeneca’s $80B sales plan leans on cancer drug expansion
BioPharma Dive via Yahoo Finance· 5 days agoBeyond 2030, the drugmaker expects to add radiopharmaceuticals, or hybrid radiation-emitting drugs,...
Boston radiopharmaceuticals startup inks deal worth up to $1.16B with Lilly - Boston Business...
The Business Journals· 6 days agoA Boston radiopharmaceuticals startup that is already backed by three Big Pharma companies now has a...
AltruBio lands up to $225M after shift to immune drug research
BioPharma Dive via Yahoo Finance· 6 days agoThe Phase 2a study AltruBio currently has underway in ulcerative colitis should produce results in...
Medicenna to Present Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming Sachs 10th Annual...
Digital Journal· 5 days agoMedicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQB: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines, announced today that it ...